Explore By Subject Area   
Return Home
Menu

Lead Podcast

Payer Perspectives on Drug Delivery

Payer Perspectives on Drug Delivery

Payers, investors and consultants about how they approach decisions to cover new medications and the role novel delivery approaches play in that decision-making.

Learn More

Featured Podcasts

The CMO as a Translational Scientist

Listen

Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles

Listen

Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness

Listen

The History of Tumor Vaccines, and Why the Newest RNA Vaccines May Work Where Others Could Not

Listen

Applying an Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials

Listen

Podcasts by Category

Clinical Trial Operations

View All
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness
Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles
Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
Accessing a Novel Source of Patient Experience Data to Improve Clinical Research
Accessing a Novel Source of Patient Experience Data to Improve Clinical Research

Immuno-Oncology and Cell Therapy

View All
Debate on Solving Immuno-Oncology's Top Challenges
Debate on Solving Immuno-Oncology's Top Challenges
The CMO as a Translational Scientist
The CMO as a Translational Scientist
The History of Tumor Vaccines, and Why the Newest RNA Vaccines May Work Where Others Could Not
The History of Tumor Vaccines, and Why the Newest RNA Vaccines May Work Where Others Could Not
Combining AI and Empirical Science to Advance Cancer Immunotherapies
Combining AI and Empirical Science to Advance Cancer Immunotherapies

Drug Delivery

View All
Payer Perspectives on Drug Delivery
Payer Perspectives on Drug Delivery
Designing and Developing Drug Delivery for LMICs
Designing and Developing Drug Delivery for LMICs
Antiviral Drug Development: How NanoViricides is Overcoming Challenges to the Current Model
Antiviral Drug Development: How NanoViricides is Overcoming Challenges to the Current Model
Sponsored
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery
Micromachines, Biologic Approaches and New Tools Pushing the Boundaries in Oral Delivery

Patients as Partners in Clinical Research and Patient Access

View All
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
Applying an Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials
Applying an Innovative Approach for Elevating Patient-Centric Solutions in Pediatric Trials
Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design
Incorporating Quantitative Values of Patient Perspectives into Clinical Trial Design
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care

Biotech CMO/R&D Leadership

View All
Strategies for CMOs to Scale Up Effectively as Their Biotech Companies Evolve
Strategies for CMOs to Scale Up Effectively as Their Biotech Companies Evolve
Patient Engagement: Practical Approaches for Emerging Biotech CMOs
Patient Engagement: Practical Approaches for Emerging Biotech CMOs
CMO Misunderstandings about Clinical Operations and How to Improve
CMO Misunderstandings about Clinical Operations and How to Improve
Sponsored
The CMO as a Translational Scientist
The CMO as a Translational Scientist

CRAACO: Clinical Research as a Care Option

View All
Making Clinical Research a Feasible Care Option Using Modern Software Infrastructure
Making Clinical Research a Feasible Care Option Using Modern Software Infrastructure
Sponsored
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
Strategies to Empower Clinical Sites, Streamline Trials and Enhance Patient Care
The Personal Impact of a Clinical Trial
The Personal Impact of a Clinical Trial
Astellas’ Head of Patient Centricity on his New Book "A Bandana and a Bluebird," and Lessons from Patients for Medicine Development
Astellas’ Head of Patient Centricity on his New Book "A Bandana and a Bluebird," and Lessons from Patients for Medicine Development

Women Leadership in Biotech

View All
How Regeneron Got an FDA-Approved Therapy for COVID in Record Time
How Regeneron Got an FDA-Approved Therapy for COVID in Record Time
A Vision for the Integration of Clinical Research and Care
A Vision for the Integration of Clinical Research and Care
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
Innovative CRISPR Editing to Create Off-the-Shelf Immune Cell Therapies
Innovative CRISPR Editing to Create Off-the-Shelf Immune Cell Therapies

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.